Press Releases - 2021-10-20

Date	Title	Company
20-Oct-2021	UCB to license its AI technology that improves identification of Osteoporosis to ImageBiopsy Lab	UCB
20-Oct-2021	TB-PRACTECAL: MSF clinical trial finds short, effective and safe drug-resistant tuberculosis treatment	Médecins Sans Frontières/Doctors Without Borders (MSF)
20-Oct-2021	PerkinElmer launches next-generation cell image analysis and management software to streamline drug discovery decision-making	PerkinElmer
20-Oct-2021	Almirall’s roadmap to a more sustainable future	Almirall
20-Oct-2021	BC Platforms Expands Partnership with Thailand’s Bumrungrad International Hospital to Accelerate Adoption of Precision Medicine in Southeast Asia	BC Platforms
20-Oct-2021	Conference Chair Di Morris, AstraZeneca invites you to join SMi's 10th Annual Pharmaceutical Microbiology Conference	SMi Group
20-Oct-2021	Interim results of a pioneering combination study in Argentina with more than 1,000 participants confirm the one-shot Sputnik Light vaccine (the first component of the Sputnik V vaccine) is an effective universal booster for vaccines produced by Astrazeneca, Sinopharm, Moderna and Cansino inducing strong immune response and showing high safety profile. Combination of AstraZeneca and Sputnik Light vaccines showed high immunogenicity results.	Russian Direct Investment Fund
20-Oct-2021	Pillar Biosciences to Collaborate with Labcorp on Precision Genomic Cancer Testing Using Next-Generation Sequencing	Pillar Biosciences
20-Oct-2021	What Impact Has Social Media Had on Physicians Ability to Treat Patients? 81% of Physicians Say Social Media Health Training Should be Taught in Medical Schools	Sermo
20-Oct-2021	Rhythm Pharmaceuticals Completes Submission of Type II Variation Application to the European Medicines Agency for IMCIVREE® (setmelanotide) for Bardet-Biedl and Alström Syndromes	Rhythm Pharmaceuticals
20-Oct-2021	Moderna Announces FDA Advisory Committee Unanimously Votes in Support of Emergency Use for a Booster Dose of Moderna’s COVID-19 Vaccine in the U.S.	Moderna
20-Oct-2021	bit.bio product launch: ioSkeletal Myocytes; the first supply of consistent, scalable, human muscle cells provide transformative new models for research and drug discovery	bit.bio
20-Oct-2021	Major investment in Swedish production of advanced vaccines and biological drugs in Matfors	NorthX Biologics
20-Oct-2021	SACITUZUMAB GOVITECAN RECEIVES POSITIVE CHMP OPINION AS 2L TREATMENT FOR ADULT PATIENTS WITH METASTATIC TRIPLE-NEGATIVE BREAST CANCER	Gilead Sciences, Inc.
20-Oct-2021	Major US hospital-based clinical trial highlights benefit of nasal decolonization to reduce ICU infections caused by Staphylococcus aureus	Destiny Pharma
20-Oct-2021	International Society for Cell and Gene Therapy and centre for Cell Manufacturing and Technologies collaborate to bridge critical skills gaps in cell and gene therapy sector	The International Society for Cell & Gene Therapy (ISCT)
20-Oct-2021	Life Sciences set down ‘a new sustainability path’ in 2022, says PHD Marketing	PHD Marketing
20-Oct-2021	New Sanofi Pasteur Australia campaign #WithVaccines	Sanofi
20-Oct-2021	AION Labs, Powered by BioMed X, Launches First Global Call for Application: Artificial Intelligence for Antibody Design	BioMed X
20-Oct-2021	Gilead Sciences Announces Veklury® Donations to Help Address the Ongoing COVID-19 Crisis in Indonesia and Armenia	Gilead Sciences